Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
63
PHG Quote, Financials, Valuation and Earnings
Last price:
$24.52
Seasonality move
:
-0.15%
Day range:
$24.01 - $24.39
52-week range:
$21.48 - $32.91
Dividend yield:
3.97%
P/E ratio:
54.05x
P/S ratio:
1.19x
P/B ratio:
1.78x
Volume:
1M
Avg. volume:
1.1M
1-year change:
-6.16%
Market cap:
$22.6B
Revenue:
$19.5B
EPS (TTM):
$0.45
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PHG
Koninklijke Philips NV
|
$5.1B | $0.29 | 3.97% | -45.61% | $32.43 |
|
ARGX
argenx SE
|
$892.6M | $3.09 | 85.28% | 502.3% | $762.96 |
|
MRUS
Merus NV
|
$9.8M | -$1.16 | 41.37% | -39.39% | $90.20 |
|
NCNA
NuCana PLC
|
-- | -$0.01 | -- | -99.69% | $104.00 |
|
PRQR
ProQR Therapeutics NV
|
$5M | -$0.17 | -26.75% | -63.67% | $8.88 |
|
QURE
uniQure NV
|
$5.8M | -$0.89 | -49.23% | -25.47% | $36.02 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PHG
Koninklijke Philips NV
|
$24.38 | $32.43 | $22.6B | 54.05x | $0.97 | 3.97% | 1.19x |
|
ARGX
argenx SE
|
$577.92 | $762.96 | $35.3B | 35.39x | $0.00 | 0% | 14.42x |
|
MRUS
Merus NV
|
$56.51 | $90.20 | $3.9B | -- | $0.00 | 0% | 69.11x |
|
NCNA
NuCana PLC
|
$0.05 | $104.00 | $304.1K | -- | $0.00 | 0% | -- |
|
PRQR
ProQR Therapeutics NV
|
$2.35 | $8.88 | $247.6M | -- | $0.00 | 0% | 10.62x |
|
QURE
uniQure NV
|
$14.42 | $36.02 | $789.5M | -- | $0.00 | 0% | 35.57x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PHG
Koninklijke Philips NV
|
39.29% | 0.957 | 34.81% | 0.69x |
|
ARGX
argenx SE
|
-- | -0.134 | -- | 6.40x |
|
MRUS
Merus NV
|
-- | 0.551 | -- | 5.34x |
|
NCNA
NuCana PLC
|
-- | -1.015 | -- | -- |
|
PRQR
ProQR Therapeutics NV
|
5.57% | 1.651 | 3.6% | 4.01x |
|
QURE
uniQure NV
|
60.5% | -5.009 | 8.9% | 11.33x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PHG
Koninklijke Philips NV
|
$1.9B | $163.1M | 2.17% | 3.18% | 4.54% | -$1.2B |
|
ARGX
argenx SE
|
$709.9M | $141.2M | 18.03% | 21.33% | 25.74% | -$147M |
|
MRUS
Merus NV
|
-- | -$75.7M | -45.56% | -45.56% | -285.94% | -$96.6M |
|
NCNA
NuCana PLC
|
-- | -$3.5M | -- | -- | -- | -$4M |
|
PRQR
ProQR Therapeutics NV
|
-- | -$11.4M | -53.43% | -58.1% | -239.35% | -$16.9M |
|
QURE
uniQure NV
|
$1.4M | -$39.3M | -158.75% | -333.08% | -1788.9% | -$44.2M |
Koninklijke Philips NV vs. Competitors
-
Which has Higher Returns PHG or ARGX?
argenx SE has a net margin of 1.86% compared to Koninklijke Philips NV's net margin of 21.43%. Koninklijke Philips NV's return on equity of 3.18% beat argenx SE's return on equity of 21.33%.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV45.13% $0.08 $20.9B ARGXargenx SE89.78% $2.58 $5.5B -
What do Analysts Say About PHG or ARGX?
Koninklijke Philips NV has a consensus price target of $32.43, signalling upside risk potential of 33.03%. On the other hand argenx SE has an analysts' consensus of $762.96 which suggests that it could grow by 32.02%. Given that Koninklijke Philips NV has higher upside potential than argenx SE, analysts believe Koninklijke Philips NV is more attractive than argenx SE.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV2 1 0 ARGXargenx SE16 1 0 -
Is PHG or ARGX More Risky?
Koninklijke Philips NV has a beta of 0.765, which suggesting that the stock is 23.523% less volatile than S&P 500. In comparison argenx SE has a beta of 0.369, suggesting its less volatile than the S&P 500 by 63.097%.
-
Which is a Better Dividend Stock PHG or ARGX?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.97%. argenx SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays -0.14% of its earnings as a dividend. argenx SE pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PHG or ARGX?
Koninklijke Philips NV quarterly revenues are $4.3B, which are larger than argenx SE quarterly revenues of $790.7M. Koninklijke Philips NV's net income of $80M is lower than argenx SE's net income of $169.5M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 54.05x while argenx SE's PE ratio is 35.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.19x versus 14.42x for argenx SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.19x 54.05x $4.3B $80M ARGXargenx SE14.42x 35.39x $790.7M $169.5M
-
Which has Higher Returns PHG or MRUS?
Merus NV has a net margin of 1.86% compared to Koninklijke Philips NV's net margin of -364.22%. Koninklijke Philips NV's return on equity of 3.18% beat Merus NV's return on equity of -45.56%.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV45.13% $0.08 $20.9B MRUSMerus NV-- -$1.40 $596.1M -
What do Analysts Say About PHG or MRUS?
Koninklijke Philips NV has a consensus price target of $32.43, signalling upside risk potential of 33.03%. On the other hand Merus NV has an analysts' consensus of $90.20 which suggests that it could grow by 59.63%. Given that Merus NV has higher upside potential than Koninklijke Philips NV, analysts believe Merus NV is more attractive than Koninklijke Philips NV.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV2 1 0 MRUSMerus NV13 0 0 -
Is PHG or MRUS More Risky?
Koninklijke Philips NV has a beta of 0.765, which suggesting that the stock is 23.523% less volatile than S&P 500. In comparison Merus NV has a beta of 0.997, suggesting its less volatile than the S&P 500 by 0.282%.
-
Which is a Better Dividend Stock PHG or MRUS?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.97%. Merus NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays -0.14% of its earnings as a dividend. Merus NV pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PHG or MRUS?
Koninklijke Philips NV quarterly revenues are $4.3B, which are larger than Merus NV quarterly revenues of $26.5M. Koninklijke Philips NV's net income of $80M is higher than Merus NV's net income of -$96.5M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 54.05x while Merus NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.19x versus 69.11x for Merus NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.19x 54.05x $4.3B $80M MRUSMerus NV69.11x -- $26.5M -$96.5M
-
Which has Higher Returns PHG or NCNA?
NuCana PLC has a net margin of 1.86% compared to Koninklijke Philips NV's net margin of --. Koninklijke Philips NV's return on equity of 3.18% beat NuCana PLC's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV45.13% $0.08 $20.9B NCNANuCana PLC-- -$0.63 -- -
What do Analysts Say About PHG or NCNA?
Koninklijke Philips NV has a consensus price target of $32.43, signalling upside risk potential of 33.03%. On the other hand NuCana PLC has an analysts' consensus of $104.00 which suggests that it could grow by 207071.32%. Given that NuCana PLC has higher upside potential than Koninklijke Philips NV, analysts believe NuCana PLC is more attractive than Koninklijke Philips NV.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV2 1 0 NCNANuCana PLC0 1 0 -
Is PHG or NCNA More Risky?
Koninklijke Philips NV has a beta of 0.765, which suggesting that the stock is 23.523% less volatile than S&P 500. In comparison NuCana PLC has a beta of 1.426, suggesting its more volatile than the S&P 500 by 42.561%.
-
Which is a Better Dividend Stock PHG or NCNA?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.97%. NuCana PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays -0.14% of its earnings as a dividend. NuCana PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PHG or NCNA?
Koninklijke Philips NV quarterly revenues are $4.3B, which are larger than NuCana PLC quarterly revenues of --. Koninklijke Philips NV's net income of $80M is higher than NuCana PLC's net income of -$3.1M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 54.05x while NuCana PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.19x versus -- for NuCana PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.19x 54.05x $4.3B $80M NCNANuCana PLC-- -- -- -$3.1M
-
Which has Higher Returns PHG or PRQR?
ProQR Therapeutics NV has a net margin of 1.86% compared to Koninklijke Philips NV's net margin of -223.04%. Koninklijke Philips NV's return on equity of 3.18% beat ProQR Therapeutics NV's return on equity of -58.1%.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV45.13% $0.08 $20.9B PRQRProQR Therapeutics NV-- -$0.11 $90.5M -
What do Analysts Say About PHG or PRQR?
Koninklijke Philips NV has a consensus price target of $32.43, signalling upside risk potential of 33.03%. On the other hand ProQR Therapeutics NV has an analysts' consensus of $8.88 which suggests that it could grow by 277.66%. Given that ProQR Therapeutics NV has higher upside potential than Koninklijke Philips NV, analysts believe ProQR Therapeutics NV is more attractive than Koninklijke Philips NV.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV2 1 0 PRQRProQR Therapeutics NV6 0 0 -
Is PHG or PRQR More Risky?
Koninklijke Philips NV has a beta of 0.765, which suggesting that the stock is 23.523% less volatile than S&P 500. In comparison ProQR Therapeutics NV has a beta of 0.365, suggesting its less volatile than the S&P 500 by 63.535%.
-
Which is a Better Dividend Stock PHG or PRQR?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.97%. ProQR Therapeutics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays -0.14% of its earnings as a dividend. ProQR Therapeutics NV pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PHG or PRQR?
Koninklijke Philips NV quarterly revenues are $4.3B, which are larger than ProQR Therapeutics NV quarterly revenues of $4.8M. Koninklijke Philips NV's net income of $80M is higher than ProQR Therapeutics NV's net income of -$10.6M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 54.05x while ProQR Therapeutics NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.19x versus 10.62x for ProQR Therapeutics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.19x 54.05x $4.3B $80M PRQRProQR Therapeutics NV10.62x -- $4.8M -$10.6M
-
Which has Higher Returns PHG or QURE?
uniQure NV has a net margin of 1.86% compared to Koninklijke Philips NV's net margin of -2784.75%. Koninklijke Philips NV's return on equity of 3.18% beat uniQure NV's return on equity of -333.08%.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV45.13% $0.08 $20.9B QUREuniQure NV87.43% -$0.82 $85.3M -
What do Analysts Say About PHG or QURE?
Koninklijke Philips NV has a consensus price target of $32.43, signalling upside risk potential of 33.03%. On the other hand uniQure NV has an analysts' consensus of $36.02 which suggests that it could grow by 149.82%. Given that uniQure NV has higher upside potential than Koninklijke Philips NV, analysts believe uniQure NV is more attractive than Koninklijke Philips NV.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV2 1 0 QUREuniQure NV9 2 0 -
Is PHG or QURE More Risky?
Koninklijke Philips NV has a beta of 0.765, which suggesting that the stock is 23.523% less volatile than S&P 500. In comparison uniQure NV has a beta of 0.077, suggesting its less volatile than the S&P 500 by 92.298%.
-
Which is a Better Dividend Stock PHG or QURE?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.97%. uniQure NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays -0.14% of its earnings as a dividend. uniQure NV pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PHG or QURE?
Koninklijke Philips NV quarterly revenues are $4.3B, which are larger than uniQure NV quarterly revenues of $1.6M. Koninklijke Philips NV's net income of $80M is higher than uniQure NV's net income of -$43.6M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 54.05x while uniQure NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.19x versus 35.57x for uniQure NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.19x 54.05x $4.3B $80M QUREuniQure NV35.57x -- $1.6M -$43.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.46% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.66% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.52% over the past day.
